Session

Monday

May 09

11:40 - 12:40

Room D1

Highlights of Proffered Papers - Latest Clinical Trials

Chair: , United Kingdom;

Chair: , The Netherlands

Overview: Proffered Papers are presented at one of the sessions scheduled in the main session halls. Each author will present orally for 7 minutes, followed by 3 minutes for discussion. Sessions will be streamed.

Session Code: 3290

Session Type: Proffered Papers

Track: Interdisciplinary

11:40 - 11:50

Acute toxicity after loco regional breast radiation therapy in the randomized DBCG SKAGEN trial 1

Marie Louise Milo, Denmark

Presentation Number: OC-0829

11:50 - 12:00

Systemic recurrence after primary chemoradiation in cervical cancer patients – an EMBRACE analysis

Johannes Knoth, Austria

Presentation Number: OC-0830

12:00 - 12:10

Results of ARTIX phase III study: adaptive radiotherapy versus standard IMRT in head and neck cancer

Renaud de Crevoisier, France

Presentation Number: OC-0831

12:10 - 12:20

DAHANCA 27, a national prospective non-inferiority study of surgery versus RT for T1a glottic cancer

Nina Munk Lyhne, Denmark

Presentation Number: OC-0832

12:20 - 12:30

Total neoadjuvant therapy for Organ Preservation in Rectal Cancer: The CAO/ARO/AIO-16 phase II trial

Cihan Gani, Germany

Presentation Number: OC-0833

12:30 - 12:40

Radiotherapy for Ledderhose disease: a randomised, double-blind, phase III trial (NCT03507010)

Anneke de Haan, The Netherlands

Presentation Number: OC-0834

ESTRO 2022

Session